Navigation Links
World BioBank(TM) Launch Benefits Advanced Medical Research
Date:4/22/2009

Human Tissue Collection and Specimen Management Provide Focus

MEMPHIS, Tenn., April 22 /PRNewswire/ -- World BioBank(TM), founded by the physician partners of Accelerated Community Oncology Research Network, Inc. (ACORN) and based in Memphis, TN (USA), has begun acquiring human tissue samples for scientific research. In addition to tissue collection, World BioBank supports biomarker storage in conjunction with clinical trial operations and provides biomarker consultation services. Specimen storage management services include inventory tracking, processing, storage and shipment. "World BioBank opens the opportunity for patient-specific, targeted therapies and as such heralds a new era of scientific commitment to research and personalized patient care," announced Lee S. Schwartzberg, MD, FACP, President of ACORN.

One of World BioBank's distinguishing features is its commitment to marry samples to a wealth of longitudinal medical data and tissue-specific data, including both pathology data and quality measures that are often very difficult to obtain. "With a strong commitment to the advancement of bioscience, World BioBank operates with an eye toward the improvement of patient outcomes. Patient well-being along with vigilance toward privacy and security directs operational decisions," added Edward J. Stepanski, PhD, COO, ACORN.

World BioBank(TM) collects cancer samples, normal samples, and other non-neoplastic diseases. Standardized intake, processing and release procedures assure the highest quality samples and data. Sample types routinely collected and housed include: solid tissues (snap frozen and matched formalin-fixed paraffin embedded diseased and normal internal controls) from surgical resections, image-guided biopsies, bone marrow biopsies and endoscopic biopsies. Liquid samples are obtained from peripheral blood, genomic DNA (from buffy coat), and plasma. Drawn from a demographically rich universe, these annotated samples offer the added information advantage of pathology, clinical and outcomes data.

Demanding SOPs help ensure high quality biospecimens. Rapid turn-around techniques ensure that both liquid and solid samples are verified and preserved within minutes of excision or draw.

Tyron (Ty) Hoover, MD, JD, serves as Executive Director of World BioBank(TM). Dr. Hoover brings special expertise to biobanking and Medico-legal issues including Informed Consent, Privacy, Bioethics. Upon completing a Pathology Residency at Baylor University Medical Center, Dr. Hoover's interest in the legal aspects of medicine led him to attain his JD, Southern Methodist University Dedman School of Law, Dallas, TX. He practiced law in Florida before serving as the Medical Director of the Biospecimen Repository and Total Cancer Care at the H. Lee Moffitt Cancer Center & Research Institute. He also co-directed the University of South Florida College of Medicine's Scholarly Concentration in Law & Medicine.

"By collecting and storing tissue and data from thousands of patients, World BioBank hopes to make a significant contribution to the fight against cancer and other diseases by providing greatly needed materials for scientists and doctors to study," remarked Dr. Hoover during World BioBank's opening. Samples will be available for both academic and private medical research.

Sample collection has begun at West Clinic, Memphis, TN. The multidisciplinary practice has over 110,000 patient encounters annually, with the potential of over 30,000 unique samples for the biorepository. "Memphis is a particularly important collection site as it offers a diverse demographic population. Other venues will be added as the year progresses," explained Dr. Schwartzberg. Cj Finke serves as Project Manager for World BioBank and handles sponsor needs for specimen management and sample requests.

For additional information visit www.WorldBioBank.net

About World BioBank (www.WorldBioBank.net)

Founded by the physician partners of ACORN (Accelerated Community Oncology Research Network), World BioBank embraces forward-thinking technology and a strong commitment to the advancement of bioscience. World BioBank provides industry and academia genetically diverse, high quality, standardized biospecimens with high quality data. Services also include biomarker storage, management and consultation for clinical trials and other scientific study.


'/>"/>
SOURCE World BioBank
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. GlaxoSmithKline and Stiefel to Create New World-Leading Specialist Dermatology Business
2. IVF Baby Born From 21-Year-Old Frozen Sperm, Ties World Record
3. Ansell Healthcare Espresses Firm Commitment to Support Continued Education of Healthcare Professionals Worldwide
4. Elsevier and Brain Mapping Foundation Co-Host 6th Annual World Congress of IBMISPS on Brain Mapping and Image Guided Therapy
5. NexGen Biofuels Ltd Signs Letter of Intent for the Purchase of World Venture Management, Inc. Assets and the Sale of its Current Business
6. Heart Hospital of Austin First Site in World to Test Efficacy of New Adult Stem Cell Therapy to Treat Damaged Heart Tissue in Phase II Trial
7. Health Care Innovations and Opportunities Attract Attendees from 40 Countries and Delegations from 12 to 6th Annual World Health Care Congress
8. Keynote Panel at Bio-IT World Expo to Feature Five Leaders in the Field of "Personal Genomics"
9. VisualSonics to Sell Mauna Kea Technologies Cellvizio(R) LAB on a Worldwide Basis to Animal Imaging Market
10. TechConnect World Announces The CancerNano 2009 Symposium May 3-7, at the George R. Brown Convention Center in Houston
11. Cepheid Announces New Diagnostic Technology to Aid World Efforts in Halting the Spread of Mycobacterium Tuberculosis (TB)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... Feb. 9, 2016  DNAtrix, a clinical ... cancer, announced that its lead product, DNX-2401, ... as an orphan medicinal product for the ... of glioma, strikes approximately 25,000 people a ... http://photos.prnewswire.com/prnh/20160208/330986LOGO --> ...
(Date:2/9/2016)... , Feb. 9, 2016 ... Inhibitors-Pipeline Insights, 2016", report provides in depth ... development activities around the Protein-Tyrosine Phosphatase 1B ... product profiles in various stages of development ... II, Phase III and Preregistration. Report covers ...
(Date:2/8/2016)... 2016 Novan, Inc. today announced that Director Robert ... Directors of Novan. In addition, Robert Keegan has been ... Carolina . --> North Carolina ... received a total of $32.8 million of net proceeds in a ... network originating throughout the Research Triangle area of North ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... and leading supplier of Semantic Graph Database technology, today announced the availability of ... of Cloudera Enterprise through the Cloudera Certified Technology Program (CCPT). AllegroGraph ...
Breaking Biology Technology:
(Date:1/22/2016)... , Jan. 22, 2016 ... addition of the "Global Biometrics Market ... their offering. --> http://www.researchandmarkets.com/research/p74whf/global_biometrics ... "Global Biometrics Market in Retail Sector ... --> Research and Markets ( ...
(Date:1/20/2016)... Jan. 20, 2016   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce the ... achievements are the result of the company,s laser focus ... eClinical , it,s comprehensive, easy-to-use and highly affordable ... --> Key MedNet growth achievements in 2015 include: ...
(Date:1/15/2016)... Rico , Jan. 15, 2016 Recent ... and small to find new ways to ensure data ... iOS and Android that ... on biometrics, transforming it into a hardware authorization token. ... users swipe their fingerprint on their KodeKey enabled device ...
Breaking Biology News(10 mins):